Nykode Therapeutics AS (FRA:5VB)
Germany · Delayed Price · Currency is EUR 0.1720
+0.0183 (11.91%)
At close: Dec 19, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of €62.13 million as of December 22, 2025. Its market cap has decreased by -21.90% in one year.
Market Cap
62.13M
Enterprise Value
10.81M
Revenue
6.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.17
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 549.42M to 62.13M, a decrease of -88.69%. That is a compound annual growth rate of -30.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 62.13M | -26.29% |
| Dec 30, 2024 | 84.29M | -86.48% |
| Dec 29, 2023 | 623.47M | -20.78% |
| Dec 30, 2022 | 787.04M | -66.41% |
| Dec 30, 2021 | 2.34B | 15.26% |
| Dec 30, 2020 | 2.03B | 270.00% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |